Research from Nagasaki University Hospital Provide New Insights into Pulmonary Aspergillosis (Drug-drug interactions in the management of non-tuberculous mycobacterial infections).

A report from Nagasaki University Hospital discusses the management of non-tuberculous mycobacterial infections (NTM-PD), a chronic respiratory infectious disease. The standard treatment for NTM-PD involves long-term multidrug therapy, including macrolides. However, the incidence of adverse events and drug-drug interactions is high, leading to low adherence rates. The report emphasizes the importance of considering drug interactions in the initiation of NTM-PD treatment and discusses the essential points to be considered in the treatment of NTM. The research highlights the challenges posed by drug interactions, particularly in cases where chronic pulmonary aspergillosis co-infects NTM-PD. [Extracted from the article]

Copyright of TB & Outbreaks Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)